Danh, Kenneth
Karp, Donna Grace
Singhal, Malvika
Tankasala, Akshaya
Gebhart, David
de Jesus Cortez, Felipe
Tandel, Devangkumar
Robinson, Peter V.
Seftel, David
Stone, Mars
Simmons, Graham
Bagri, Anil
Schreiber, Martin A.
Buser, Andreas http://orcid.org/0000-0002-7942-6746
Holbro, Andreas
Battegay, Manuel
Morris, Mary Kate
Hanson, Carl
Mills, John R. http://orcid.org/0000-0003-1025-4760
Granger, Dane
Theel, Elitza S. http://orcid.org/0000-0002-6886-2294
Stubbs, James R. http://orcid.org/0000-0002-3270-4913
Corash, Laurence M. http://orcid.org/0000-0002-8615-9869
Tsai, Cheng-ting http://orcid.org/0000-0002-8718-8821
Article History
Received: 31 January 2022
Accepted: 4 July 2022
First Online: 21 July 2022
Competing interests
: K.D., D.K., M.S., A.T., D.T., F.J.C., D.G., P.V.R., D.S., and C.T.T. were employed by Enable Biosciences. F.J.C., D.G., K.D., D.T., P.V.R., D.S., and C.T.T. are shareholders of Enable Biosciences. P.V.R. and C.T.T. are inventors of the ADAP patent US11149296B2 licensed from the University of California, Berkeley to Enable Biosciences. The ADAP and SONIA assay used in this study is a product in development. This does not alter our adherence to journal policies on sharing data and materials. A.B. and L.M.C. were employees and shareholders of Cerus Corporation, a manufacturer of a convalescent plasma inactivation system. The remaining authors declare no competing interests.